Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck KGaA Develops Asia Hub In Taiwan, Looking To Expand

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Merck KGaA and Taiwan's Development Center for Biotechnology announced Oct. 29 the opening of Merck's Asian Technology and Training Center in Taiwan

You may also be interested in...



Taiwan Government Supports Creating Solid Clinical Trial Environment - DIA Exclusive 

BOSTON - Taiwan's Bureau of Pharmaceutical Affairs and Center for Drug Evaluation brought a large delegation to promote the country's clinical trial environment at the Drug Information Association's 44th annual meeting held this year in Boston. BPA Deputy-Director General Li-Ling Liu and CDE Executive Director Herng-Der Chern, spoke with PharmAsia News on the sidelines of the conference about the country's efforts to make Taiwan an attractive location for clinical development

Taiwan Cabinet Approves WTO TRIPS Amendment

Taiwan's Cabinet gave its approval of intellectual property rights regulations adopted by the World Trade Organization. The WTO amendment remains to be ratified by the end of next year by Taiwan's legislature. The Trade-Related Aspects of Intellectual Property Rights allows countries without makers of generics drugs to import generics under a well-defined compulsory licensing procedure. (Click here for more

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

LL1127674

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel